Seaweed extract may tackle fatty liver Disease—A trial puts it to the test

NCT ID NCT07763626

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This study tests whether a supplement made from brown algae and chromium picolinate, when added to a calorie-controlled Mediterranean diet, can reduce fat buildup in the liver. Adults with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic syndrome will take either the supplement or a placebo for six months. Researchers will measure changes in liver fat, weight, waist size, blood sugar, cholesterol, and liver health to see if the supplement offers extra benefits beyond diet alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
A dietary supplement containing brown algae extracts (Ascophyllum nodosum and Fucus vesiculosus) and chromium picolinate, taken alongside a hypocaloric Mediterranean diet.
What this could lead to
If effective, this supplement could offer a natural, well-tolerated addition to diet and lifestyle changes for reducing liver fat and improving metabolic health in people with MASLD.
What could go wrong
This is a 6-month study with a modest sample size, and the supplement's benefits beyond diet alone remain uncertain. Possible side effects or lack of significant improvement over placebo are risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Genoa

    Genova, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.